Frederick G. Vogt
2020
Compensation breakdown
| Non-Equity Incentive Plan | $84,000 |
|---|---|
| Option Awards | $2,441,820 |
| Salary | $420,000 |
| Other | $11,400 |
| Total | $2,957,220 |
Vogt received $2.4M in option awards, accounting for 83% of the total pay in 2020.
Vogt also received $84K in non-equity incentive plan, $420K in salary and $11.4K in other compensation.
Rankings
In 2020, Frederick G. Vogt's compensation ranked 3,911th out of 13,090 executives tracked by ExecPay. In other words, Vogt earned more than 70.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,911 out of 13,090 | 70th |
Division Manufacturing | 1,559 out of 5,621 | 72nd |
Major group Chemicals And Allied Products | 590 out of 2,254 | 74th |
Industry group Drugs | 508 out of 1,954 | 74th |
Industry Biological Products, Except Diagnostic Substances | 119 out of 411 | 71st |
Pay ratio
| Frederick G. Vogt's Pay | $2,957,220 |
|---|---|
| Median Employee's Pay | $445,643 |
| Pay Ratio | 7to 1 |
In 2020, the annual total compensation of Frederick G. Vogt was $2,957,220.
The annual total compensation of the median employee at Lion Biotechnologies was $445,643.
The ratio of Frederick G. Vogt's pay to the pay of median employee was therefore 7 to one.
Vogt's colleagues
We found five more compensation records of executives who worked with Frederick G. Vogt at Lion Biotechnologies in 2020.
2020
Maria Fardis
Lion Biotechnologies
Chief Executive Officer
2020
Jean-Marc Bellemin
Lion Biotechnologies
Chief Financial Officer
2020
Friedrich Finckenstein
Lion Biotechnologies
Chief Medical Officer
2020
Michael Swartzburg
Lion Biotechnologies
Former Vice President, Finance and interim Principal Financial Officer and Principal Accounting Officer
2020
Timothy Morris
Lion Biotechnologies